GB1496333A - Vaccine compositions - Google Patents

Vaccine compositions

Info

Publication number
GB1496333A
GB1496333A GB29419/77A GB2941977A GB1496333A GB 1496333 A GB1496333 A GB 1496333A GB 29419/77 A GB29419/77 A GB 29419/77A GB 2941977 A GB2941977 A GB 2941977A GB 1496333 A GB1496333 A GB 1496333A
Authority
GB
United Kingdom
Prior art keywords
group
acyl
muramyl
aminoacids
oligomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB29419/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of GB1496333A publication Critical patent/GB1496333A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB29419/77A 1974-07-01 1974-10-23 Vaccine compositions Expired GB1496333A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7422909A FR2292486A1 (fr) 1974-07-01 1974-07-01 Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de microbacteries et autres micro-organismes

Publications (1)

Publication Number Publication Date
GB1496333A true GB1496333A (en) 1977-12-30

Family

ID=9140751

Family Applications (1)

Application Number Title Priority Date Filing Date
GB29419/77A Expired GB1496333A (en) 1974-07-01 1974-10-23 Vaccine compositions

Country Status (2)

Country Link
FR (1) FR2292486A1 (ja)
GB (1) GB1496333A (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050856A2 (en) * 1980-10-27 1982-05-05 Fujisawa Pharmaceutical Co., Ltd. New peptide, process for its preparation and pharmaceutical composition containing it
EP1617860A2 (en) * 2003-04-09 2006-01-25 Vladimir Slesarev Biodegradable glucosaminemuramyl peptides for apoptosis modulation

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2358159A1 (fr) * 1976-07-16 1978-02-10 Anvar Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2466455A2 (fr) * 1979-10-05 1981-04-10 Anvar Nouveaux composes hydrosolubles, provenant d'extraits de streptomyces stimulosus, leur obtention, leur application a titre d'adjuvants immunologiques et compositions les contenant
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
DE3070278D1 (en) * 1979-10-11 1985-04-18 Fujisawa Pharmaceutical Co Peptides, processes for their preparation and pharmaceutical compositions containing them
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
FR2529463B1 (fr) * 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050856A2 (en) * 1980-10-27 1982-05-05 Fujisawa Pharmaceutical Co., Ltd. New peptide, process for its preparation and pharmaceutical composition containing it
EP0050856A3 (en) * 1980-10-27 1982-08-04 Fujisawa Pharmaceutical Co. Ltd. New peptide, process for its preparation and pharmaceutical composition containing it
EP1617860A2 (en) * 2003-04-09 2006-01-25 Vladimir Slesarev Biodegradable glucosaminemuramyl peptides for apoptosis modulation
EP1617860A4 (en) * 2003-04-09 2006-12-13 Vladimir Slesarev GLUCOSAMINEMURAMYL BIODEGRADABLE PEPTIDES FOR MODULATION OF APOPTOSIS

Also Published As

Publication number Publication date
FR2292486B1 (ja) 1979-08-10
FR2292486A1 (fr) 1976-06-25

Similar Documents

Publication Publication Date Title
GB1496333A (en) Vaccine compositions
DK93584A (da) Haemophilus-b-influenza polysaccharid exotoxoid-konjugatvaccine
MY107056A (en) Lactam free cyclic amino acids.
KR960033469A (ko) 단일주사 백신 제형
AU7038587A (en) Amino acid chelated compositions
DE69118389D1 (de) Verbesserte vakzinzusammensetzung
WO1991005754A3 (fr) Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophiques et cytoprotectrices, et compositions pharmaceutiques les contenant
CA2240541A1 (en) Stabilisers for live vaccines
MXPA04004228A (es) Copolimeros utiles para acidos de gelificacion.
ES8407000A1 (es) Un procedimiento para la preparacion de una dispersion nacarada de esteres glicolicos.
CA2004163A1 (en) Dry cleaning fluid with curable amine functional silicone for fabric wrinkle reduction
ZA91381B (en) Polyanhydrides of oligomerized unsaturated aliphatic acids
PL323457A1 (en) Vaccine composition containing polyribositoloribitol phosphate and method of obtaining same
ES2014060A6 (es) Procedimiento para la obtencion de productos farmaceuticos que actuan en particualr sobre el corazon y el sistema cardiovascular.
EP0122688A3 (en) Crystalline copolyamides from terephthalic acid, isophthalic acid and c6 diamines
GB1477797A (en) Hydroxypropyl starch acetate having elastic properties
DE69027397T2 (de) Carbohydratacryl- und -methacrylcopolymere und ihre herstellung
ES8605041A1 (es) Procedimiento de preparacion de polisacaridos membranarios de origen bacteriano
GB1335204A (en) Preparation of polyacetylalkylene diamines
CA2050992A1 (en) Fiber treatment agent
GB1515902A (en) Polylauric lactam method of making higher polylactams and their application
AU4951590A (en) Textile conditioners
BR9801348A (pt) Composição de revestimento e método para intensificar as propriedades de deslizamento em uma composição de revestimento
GB1147749A (en) Synthetic lubricant composition
NZ511118A (en) Activation of cellular immunity with antigenic proteins and hydrophobized polysaccharides, which have modified alkyl or cholesterol groups

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee